Your browser doesn't support javascript.
loading
The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them.
Smith, Martyn T; Guyton, Kathryn Z; Kleinstreuer, Nicole; Borrel, Alexandre; Cardenas, Andres; Chiu, Weihsueh A; Felsher, Dean W; Gibbons, Catherine F; Goodson, William H; Houck, Keith A; Kane, Agnes B; La Merrill, Michele A; Lebrec, Herve; Lowe, Leroy; McHale, Cliona M; Minocherhomji, Sheroy; Rieswijk, Linda; Sandy, Martha S; Sone, Hideko; Wang, Amy; Zhang, Luoping; Zeise, Lauren; Fielden, Mark.
Afiliação
  • Smith MT; Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California. martynts@berkeley.edu.
  • Guyton KZ; Monographs Programme, International Agency for Research on Cancer, Lyon, France.
  • Kleinstreuer N; Division of Intramural Research, Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, North Carolina.
  • Borrel A; National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
  • Cardenas A; Division of Intramural Research, Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, North Carolina.
  • Chiu WA; Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California.
  • Felsher DW; Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas.
  • Gibbons CF; Division of Oncology, Departments of Medicine and Pathology, Stanford University School of Medicine, Stanford, California.
  • Goodson WH; Office of Research and Development, US Environmental Protection Agency, Washington, D.C.
  • Houck KA; California Pacific Medical Center Research Institute, San Francisco, California.
  • Kane AB; Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, North Carolina.
  • La Merrill MA; Department of Pathology and Laboratory Medicine, Alpert Medical School, Brown University, Providence, Rhode Island.
  • Lebrec H; Department of Environmental Toxicology, University of California, Davis, California.
  • Lowe L; Comparative Biology & Safety Sciences, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • McHale CM; Getting to Know Cancer, Truro, Nova Scotia, Canada.
  • Minocherhomji S; Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California.
  • Rieswijk L; Comparative Biology & Safety Sciences, Amgen Research, Amgen Inc., Thousand Oaks, California.
  • Sandy MS; Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California.
  • Sone H; Institute of Data Science, Maastricht University, Maastricht, the Netherlands.
  • Wang A; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, California.
  • Zhang L; Yokohama University of Pharmacy and National Institute for Environmental Studies, Tsukuba Ibaraki, Japan.
  • Zeise L; Office of the Report on Carcinogens, Division of National Toxicology Program, The National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
  • Fielden M; Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California.
Cancer Epidemiol Biomarkers Prev ; 29(10): 1887-1903, 2020 10.
Article em En | MEDLINE | ID: mdl-32152214
The key characteristics (KC) of human carcinogens provide a uniform approach to evaluating mechanistic evidence in cancer hazard identification. Refinements to the approach were requested by organizations and individuals applying the KCs. We assembled an expert committee with knowledge of carcinogenesis and experience in applying the KCs in cancer hazard identification. We leveraged this expertise and examined the literature to more clearly describe each KC, identify current and emerging assays and in vivo biomarkers that can be used to measure them, and make recommendations for future assay development. We found that the KCs are clearly distinct from the Hallmarks of Cancer, that interrelationships among the KCs can be leveraged to strengthen the KC approach (and an understanding of environmental carcinogenesis), and that the KC approach is applicable to the systematic evaluation of a broad range of potential cancer hazards in vivo and in vitro We identified gaps in coverage of the KCs by current assays. Future efforts should expand the breadth, specificity, and sensitivity of validated assays and biomarkers that can measure the 10 KCs. Refinement of the KC approach will enhance and accelerate carcinogen identification, a first step in cancer prevention.See all articles in this CEBP Focus section, "Environmental Carcinogenesis: Pathways to Prevention."
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinógenos / Biomarcadores / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinógenos / Biomarcadores / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
...